The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies

Chimeric antigen receptor (CAR) T cells have been successfully used in the therapy of B cell leukemia and lymphoma, but still have many challenges in their use for treating T cell malignancies, such as the lack of unique tumor antigens, their limitation of T cell expansion, and the need for third pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Diwei, Wang, Xindong, Cheng, Lin, Qin, Le, Jiang, Zhiwu, Zhao, Ruocong, Li, Yao, Shi, Jingxuan, Wu, Qiting, Long, Youguo, Wang, Suna, Tang, Zhaoyang, Wei, Wei, Yang, Jie, Li, Yangqiu, Zhou, Hongsheng, Liu, Qifa, Liu, Pentao, Chen, Xinwen, Yao, Yao, Yang, LiHua, Li, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182403/
https://www.ncbi.nlm.nih.gov/pubmed/35693763
http://dx.doi.org/10.3389/fimmu.2022.808347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182403/
https://www.ncbi.nlm.nih.gov/pubmed/35693763
http://dx.doi.org/10.3389/fimmu.2022.808347

Ejemplares similares